Clinical Trial Detail

NCT ID NCT03901573
Title High-Risk Skin Cancers With Atezolizumab Plus NT-I7
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NeoImmuneTech
Indications

skin squamous cell carcinoma

Merkel cell carcinoma

melanoma

Therapies

Atezolizumab + NT-I7

Age Groups: senior adult

No variant requirements are available.